What is the recommended management for Mal de Débarquement Syndrome?

Management of Mal de Débarquement Syndrome

The most effective treatment for Mal de Débarquement Syndrome is vestibular ocular reflex (VOR) readaptation using optokinetic stimulation paired with head roll movements, which provides symptom relief in approximately two-thirds of patients. 1

Primary Treatment: VOR Readaptation Protocol

The standardized VOR readaptation protocol should be your first-line intervention for MdDS patients, regardless of whether symptoms were motion-triggered or spontaneous-onset 1:

• Administer optokinetic stimulation (OKS) paired with fixed head roll at 0.167 Hz over 2-5 consecutive days 1
• Schedule four 4-minute treatment blocks daily: two in the morning and two in the afternoon 1
• This protocol achieves a 64.1% overall success rate, with no significant difference between motion-triggered (64.2%) and spontaneous-onset (63.3%) cases 1
• Both subjective symptom scores and objective posturography measures show significant improvement post-treatment 1

Alternative Delivery Method

Virtual reality applications can effectively replace the traditional OKS booth, making treatment more accessible worldwide 2:

• VR-based treatment demonstrates non-inferiority to the standard booth method 2
• The same protocol (four 4-minute blocks over four consecutive days) applies 2
• This option significantly improves treatment accessibility for patients who cannot travel to specialized centers 2

Adjunctive Pharmacologic Management

When VOR rehabilitation alone is insufficient, consider managing MdDS as vestibular migraine 3:

• 73% of MdDS patients respond to vestibular migraine prophylaxis protocols 3
• First-line medications include verapamil, nortriptyline, topiramate, or combinations thereof 3
• Nearly all MdDS patients have personal or family history of migraine or atypical migraine symptoms 3
• This approach outperforms vestibular rehabilitation and physical therapy alone in retrospective comparisons 3

Acute Symptom Management

For severe acute symptoms, clonazepam provides symptomatic relief 4:

• Use benzodiazepines judiciously and for limited duration only 4
• Be aware that all benzodiazepines carry significant risk for drug dependence 5
• Reserve for acute exacerbations rather than chronic management 4

Lifestyle Modifications

Implement these evidence-based lifestyle changes to reduce symptom triggers 5:

• Limit sodium intake to 1500-2300 mg daily (American Heart Association recommendation adapted for vestibular disorders) 5
• Avoid excessive caffeine, alcohol, and nicotine 5
• Maintain adequate hydration with water, avoiding high-sugar beverages 5
• Ensure sufficient sleep and regular exercise 5
• Implement stress management techniques including meditation, breathing exercises, and support groups 5
• Assess for and manage sleep apnea in patients with increased vertigo episodes 5

Emerging Therapies

Intermittent theta burst stimulation (iTBS) over the dorsolateral prefrontal cortex does not enhance VOR rehabilitation outcomes 6:

• A 2024 randomized controlled trial found no additional benefit when iTBS was added to VOR rehabilitation 6
• Both active and sham iTBS groups showed equivalent improvements 6
• VOR rehabilitation alone remains the evidence-based standard 6

Treatment Algorithm

1. Start with standardized VOR readaptation protocol (OKS with head roll) over 2-5 days 1
2. If booth unavailable, use virtual reality application with identical protocol 2
3. For partial responders or non-responders, add vestibular migraine prophylaxis (verapamil, nortriptyline, or topiramate) 3
4. Implement lifestyle modifications concurrently with all treatments 5
5. Reserve benzodiazepines for acute symptom management only, avoiding chronic use 4

Important Caveats

• Treatment success is independent of onset type: Motion-triggered and spontaneous-onset MdDS respond equally well to VOR readaptation 1
• Age and flight duration matter for pilots: Older pilots with longer flight times experience more severe symptoms and greater quality-of-life impairment 7
• Female patients may experience worse quality-of-life: Gender differences exist in symptom severity and treatment response 7
• The scoping review confirms that multiple treatment modalities show promise, but VOR rehabilitation has the strongest evidence base 8